References
- Prentis RA, Lis Y, Walker SR. Pharmaceutical innovation by seven UK-owned pharmaceutical companies (1964–1985). Br J Clin Pharmacol. 1988;25:387–96.
- Nadkarni S. Theory & practice for development of enabling formulations for preclinical studies. 2010. Available from: http://www.caco-ba.org/htmls/Documents/Public%20References/2010Jan20_Joint_Meeting/Development%20of%20Enabling%20Formulations_Nadkarni.pdf [Accessed August 2012].
Recommended Reading
- Rang HP, Dale MM, Ritter JM. Pharmacology. 3rd ed.New York: Churchill Livingstone; 1995.
- Kolthammer J. Pharmacokinetics … a beginner’s guide.Buckinghamshire: The Institute of Clinical Research; 2007.
- Persiani S. Course notes from introduction to pharmacokinetics for the non-specialist hosted by Pharmaceutical Training International, 2009.
- Rang HP, Dale MM, Ritter JM. Pharmacology. 3rd ed. New York: Churchill Livingstone; 1995. Kolthammer J. Pharmacokinetics … a beginner’s guide. Buckinghamshire: The Institute of Clinical Research; 2007.
- Julious SA, Tan SB, Machin D. An introduction to statistics in early phase trials. John Chichester: Wiley & Sons Ltd; 2010.